Literature DB >> 16958029

Association of the human kainate receptor GluR7 gene (GRIK3) with recurrent major depressive disorder.

H H Schiffer1, S F Heinemann.   

Abstract

The etiology of mood disorders remains elusive, despite our increasing understanding of the neurotransmitter systems and brain regions that are involved. We performed a large family-based association study to test if the human kainate receptor GluR7 gene (GRIK3) is associated with bipolar disorder (BP) or recurrent major depressive disorder (R-MDD). One hundred fifty-three multiplex BP families from the National Institute of Mental Health (NIMH) Genetics Initiative on Bipolar Disorder were analyzed with the transmission disequilibrium test (TDT). We detected a significant linkage disequilibrium (LD) indicated by preferential maternal transmission of the GluR7 S310 allele to R-MDD patients (P = 0.012), but not to bipolar I disorder (BPI) patients (P = 1.00). We performed a second independent study by applying the TDT in 81 parent-offspring triads from families that inherit recurrent early-onset major depressive disorder (RE-MDD). The results from this second study showed only a suggestive maternal association (P = 0.068). Our findings imply that the GluR7 gene is a susceptibility factor in R-MDD and that the glutamatergic receptor system plays a critical role in the disease etiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16958029     DOI: 10.1002/ajmg.b.30374

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  25 in total

1.  Pharmacogenetics of glutamate system genes and SSRI-associated sexual dysfunction.

Authors:  Jeffrey R Bishop; Sharon S Chae; Shitalben Patel; Jessica Moline; Vicki L Ellingrod
Journal:  Psychiatry Res       Date:  2012-04-24       Impact factor: 3.222

2.  GluR7 is an essential subunit of presynaptic kainate autoreceptors at hippocampal mossy fiber synapses.

Authors:  Paulo S Pinheiro; David Perrais; Françoise Coussen; Jacques Barhanin; Bernhard Bettler; Jeffrey R Mann; João O Malva; Stephen F Heinemann; Christophe Mulle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

3.  A Neural "Tuning Curve" for Multisensory Experience and Cognitive-Perceptual Schizotypy.

Authors:  Francesca Ferri; Yuliya S Nikolova; Mauro Gianni Perrucci; Marcello Costantini; Antonio Ferretti; Valentina Gatta; Zirui Huang; Richard A E Edden; Qiang Yue; Marco D'Aurora; Etienne Sibille; Liborio Stuppia; Gian Luca Romani; Georg Northoff
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 4.  Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population.

Authors:  Charlene Faye; Josephine C Mcgowan; Christine A Denny; Denis J David
Journal:  Curr Neuropharmacol       Date:  2018-03-05       Impact factor: 7.363

5.  Modeling prior information of common genetic variants improves gene discovery for neuroticism.

Authors:  Min-Tzu Lo; Yunpeng Wang; Karolina Kauppi; Nilotpal Sanyal; Chun-Chieh Fan; Olav B Smeland; Andrew Schork; Dominic Holland; David A Hinds; Joyce Y Tung; Ole A Andreassen; Anders M Dale; Chi-Hua Chen
Journal:  Hum Mol Genet       Date:  2017-11-15       Impact factor: 6.150

6.  Heritability and molecular genetic basis of acoustic startle eye blink and affectively modulated startle response: a genome-wide association study.

Authors:  Uma Vaidyanathan; Stephen M Malone; Michael B Miller; Matt McGue; William G Iacono
Journal:  Psychophysiology       Date:  2014-12       Impact factor: 4.016

Review 7.  Kainate receptors coming of age: milestones of two decades of research.

Authors:  Anis Contractor; Christophe Mulle; Geoffrey T Swanson
Journal:  Trends Neurosci       Date:  2011-01-20       Impact factor: 13.837

Review 8.  Novel glutamatergic agents for major depressive disorder and bipolar disorder.

Authors:  Rodrigo Machado-Vieira; Lobna Ibrahim; Ioline D Henter; Carlos A Zarate
Journal:  Pharmacol Biochem Behav       Date:  2011-09-25       Impact factor: 3.533

Review 9.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

Review 10.  The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.

Authors:  Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Neuroscientist       Date:  2009-05-26       Impact factor: 7.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.